While ideological opponents continue to do everything they can to eliminate Medicare Advantage, the research evidence continues to show benefits from the program over traditional fee-for-service Medicare. (NBER Paper) To avoid selection bias issues which might result from unobservably healthier beneficiaries enrolling in Medicare Advantage, the authors used a feature of Medicare Advantage payments that gives higher reimbursement to plans in counties with populations over 250,000 as a basis for analysis. While it is generally unquestioned that Medicare pays Medicare Advantage more for a particular beneficiary than that beneficiary would cost in traditional Medicare, that is an intentional political decision that Congress made. Whether or not more is actually spent on their care is a different question, as is the issue of comparative quality. At this point, there appears to be accumulating evidence that quality is better in Medicare Advantage plans. And there is more evidence than not that there is lower utilization, particularly of low-value services, in the Medicare Advantage plans. The authors try to extend these analyses by finding a way to eliminate unknown variables between the Medicare Advantage and fee-for-service populations. They compared outcomes from beneficiaries in counties with populations from 100,000 to 249,999 to counties with populations from 250,000 to 400,000 persons. They incorporate beneficiary and country characteristics into their analysis. The larger, higher Medicare Advantage reimbursement counties have more Medicare Advantage enrollment, as might be expected. After all the adjustments, the analysis shows over a 20% reduction in hospital admissions for Medicare Advantage, along with lower mortality, demonstrating once again that Medicare Advantage plans are likely delivering more appropriate care, usually with better outcomes.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Another over-hyped digital health company screws shareholders who bought the hype, as Babylon Health has to bail itself out by going private, with nothing being returned to ordinary shareholders. The...
June 26, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace